STERLING BIOTECH Limited Unlisted Shares - Company Overview
Sterling Biotech Limited capabilities include state of art research centre, advance pilot plant for scale up studies, modern facility of bioreactors and range of down streaming process equipments. All these are coupled with dedicated and qualified work force, well equipped quality control laboratory and quality assurance systems. We strive to become leaders in API pharmaceutical area by developing state of the art facility for research and development, contract manufacturing of active pharmaceutical ingredients. We build quality in every aspect of manufacturing with particular laid down emphasis based on current Good Manufacturing Practices.
|
|||||||||||||||||||||||||||||
|
STERLING BIOTECH LIMITED Incorporation Details |
|
|
STERLING BIOTECH LIMITED CIN Number |
L51900MH1985PLC035738 |
|
STERLING BIOTECH LIMITED Registration Date |
23-Mar-85 |
|
Category / Sub-Category of STERLING BIOTECH LIMITED |
Public Companies having a share capital |
|
STERLING BIOTECH LIMITED Registered Office Address |
601, Windfall Building, Sahar Plaza Complex, Near Hotel Kohinoor, (Andheri East) J.B. Nagar Mumbai Mumbai MH 400059 IN. |
|
STERLING BIOTECH LIMITED Limited Registrar & Transfer Agent Address & Contact Details |
Link Intime India Pvt. Ltd |
STERLING BIOTECH LIMITED Board of Directors
|
Director |
Post |
|
Mr.Nitin Sandesara |
Director |
|
Mr. Vilas Joshi |
Director |
|
Mr.Priyadarshan Mehta |
Director |
|
Mr. Chetan Sandesara |
Director |
|
Mr. Rajbhushan Dixit |
Director |
|
Mrs. Mayuriben Patel |
Director |
STERLING BIOTECH LIMITED Principal Business Activities
|
Name and Description of main products/services |
NIC Code of the product/service* |
% to the total turnover of the Company |
|
Manufacture of gelatin and its derivatives, resinoids, glues |
20295
|
79.00% |
|
Manufacture of allopathic pharmaceutical preparations
|
21002
|
21.00% |
STERLING BIOTECH LIMITED Shareholding Pattern (As of 31-03-2017)
|
Particulars |
No. Of Shares |
% of Shares Held |
|
Promoter |
7,05,26,090 |
25.91% |
|
Public Shareholding |
17,59,27,437 |
64.64% |
|
Others |
2,57,16,861 |
9.45% |
|
Total |
27,21,70,388 |
100 |
